萘普西諾 |
|
其他名稱 | AZD-3582, HCT-3012 |
---|
ATC碼 | |
---|
|
4-nitrooxybutyl (2S)-2-(6-methoxynaphthalen-2-yl)propanoate
|
CAS號 | 163133-43-5 Y |
---|
PubChem CID | |
---|
ChemSpider | |
---|
UNII | |
---|
KEGG | |
---|
ChEBI | |
---|
CompTox Dashboard (EPA) | |
---|
|
化學式 | C18H21NO6 |
---|
摩爾質量 | 347.37 g·mol−1 |
---|
3D模型(JSmol) | |
---|
C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)OCCCCO[N+](=O)[O-]
|
InChI=1S/C18H21NO6/c1-13(18(20)24-9-3-4-10-25-19(21)22)14-5-6-16-12-17(23-2)8-7-15(16)11-14/h5-8,11-13H,3-4,9-10H2,1-2H3/t13-/m0/s1 NKey:AKFJWRDCWYYTIG-ZDUSSCGKSA-N N
|
萘普西諾(英語:Naproxcinod或nitronaproxen)是一種有機化合物,化學式為C18H21NO6,屬於萘普生的衍生物,由法國製藥公司NicOx作為非甾體抗炎藥(NSAID)開發[1][2]。
- ^ Ellis JL, Augustyniak ME, Cochran ED, Earl RA, Garvey DS, Gordon LJ, et al. NMI-1182, a gastro-protective cyclo-oxygenase-inhibiting nitric oxide donor. Inflammopharmacology. 2005, 12 (5–6): 521–534. PMID 16259719. S2CID 3231846. doi:10.1163/156856005774382661.
- ^ Cirino G, Distrutti E, Wallace JL. Nitric oxide and inflammation. Inflammation & Allergy - Drug Targets. April 2006, 5 (2): 115–119. CiteSeerX 10.1.1.628.532 . PMID 16613570. doi:10.2174/187152806776383143.